Table 3 Relationship between serum TC and lumbar BMD

Male

TC (mmol/L)

3.169(2.583, 3.756)

<0.001 ^***

-0.257(-0.752, 0.239)

0.309

3.978(2.088, 5.867)

<0.001 ^***

Q1

Reference

Reference

Reference

Q2

6.221 (4.590, 7.852)

<0.001^***

-0.776(-2.144, 0.591)

0.265

0.551(-1.107, 2.208)

0.538

Q3

6.651(5.024, 8.277)

<0.001^***

-1.071(-2.437, 0.296)

0.125

0.914 (-1.177, 3.005)

0.401

Q4

8.340(6.713, 9.967)

<0.001^***

-0.833(-2.205, 0.540)

0.234

2.324(-0.584, 5.232)

0.117

P for trend

<0.001 ^***

0.212

0.145

Female

TC (mmol/L)

-5.721 (-6.732, -4.710)

<0.001 ^***

-1.423(-2.390, -0.961)

<0.001 ^***

-0.269(-3.409, 2.067)

0.842

Q1

Reference

Reference

Reference

Q2

2.253 (-0.517, 5.024)

0.103

-2.333(-4.226, -0.439)

0.016^*

-1.292(-3.513, 0.929)

0.242

Q3

-5.589(-8.362, -2.815)

<0.001^***

-2.787(-4.681, -0.893)

0.004^**

-1.391(-4.252, 1.470)

0.340

Q4

-14.203(-16.969, -11.437)

<0.001^***

-4.171(-6.072, -2.271)

<0.001^***

-2.405(-6.481, 1.672)

0.243

P for trend

<0.001 ^***

<0.001 ^***

0.305